A new clinical trial is underway for victims of mesothelioma. The Mesothelioma Center of NewYork-Presbyterian Hospital and Columbia University Medical Center is actively recruiting patients for a clinical research study of a targeted radiation and chemotherapy protocol for pleural mesothelioma. According to Dr. Robert Taub, the study’s principal investigator, the Mesothelioma Center is the only hospital in the country offering the experimental therapy to mesothelioma sufferers. At present, the standard protocol for treatment of pleural mesothelioma requires surgery to remove the lung. Dr. Taub and his team will investigate whether the new protocol can benefit patients while at the same time avoiding surgery and reducing the toxic side affects associated with systemic chemotherapy. Clinical trial patients will receive chemotherapy drugs cisplatin and doxorubicin by surgically implanted catheters. Some patients will also receive cisplatin and pemetrexed intravenously. In addition, all study participants will receive targeted radiotherapy using the P-32 radioisotope.
Source
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment